Famille C is a single-family office that invests permanent capital primarily in beauty, wellness technology, biotech, and luxury hospitality ventures. Their strategy involves taking minority or majority stakes with a long-term vision, focusing on patient ownership and supporting entrepreneurs who are transforming global premium skincare and well-being.
50% of their portfolio is in Biotech & Life Sciences.
Portfolio
2
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Spore.Bio | Series A | $22M | Feb 2025 |
| LLe Collectionist | Unknown | $60M | Dec 2022 |
Top Co-Investors
Highland Europe1 shared
Pictet1 shared
Lombard Odier1 shared
Red River West1 shared
LocalGlobe1 shared
Singular1 shared
Point 721 shared
1st Kind Ventures1 shared
Station F1 shared
No Label Ventures1 shared
Last updated: 28 April 2026